Monoclonal antibodies to CD44 epitopes on mouse endothelium

S. M. Davern, P. K. Lankford, L. J. Foote, Stephen Kennel

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

CD44 is a widely expressed, plasma membrane protein. Many molecular forms of CD44 are possible as it is encoded by a gene with multiple exons that can be alternatively spliced and its deduced protein sequence contains numerous glycosylation sites. Through its role as an adhesion molecule, CD44 is involved in many and diverse biological processes, including angiogenesis, lymphogenesis, wound healing, inflammation, and cancer metastasis. We have developed a new panel of rat monoclonal antibodies (MAbs) to murine CD44 by immunization with mouse lung endothelial cells (LEII cells). The antibodies were characterized using immunoprecipitation, mass spectrometry, competition binding, and cross Western blot experiments with MAb 133-13A, which recognizes CD44 expressed on tumor cells. The new MAbs recognize three distinct epitope groups. MAbs 531-2A and 531-32A compete for binding with the MAb 133-13A that was described previously. MAb 531-30A identifies a CD44 epitope found on low molecular weight forms expressed in vivo, while MAb 531-22A appears to recognize an epitope specific for endothelial cells. This novel panel of anti-CD44 antibodies has potential for investigating the role of CD44 in disease pathogenesis models in the mouse. They may be particularly useful for examining the role of endothelial cells in these models.

Original languageEnglish (US)
Pages (from-to)339-349
Number of pages11
JournalHybridoma and Hybridomics
Volume21
Issue number5
DOIs
StatePublished - Jan 1 2002

Fingerprint

Endothelium
Epitopes
Endothelial Cells
Monoclonal Antibodies
Biological Phenomena
Glycosylation
Immunoprecipitation
Wound Healing
Blood Proteins
Anti-Idiotypic Antibodies
Exons
Immunization
Mass Spectrometry
Neoplasms
Membrane Proteins
Molecular Weight
Western Blotting
Cell Membrane
Neoplasm Metastasis
Inflammation

All Science Journal Classification (ASJC) codes

  • Immunology
  • Genetics

Cite this

Monoclonal antibodies to CD44 epitopes on mouse endothelium. / Davern, S. M.; Lankford, P. K.; Foote, L. J.; Kennel, Stephen.

In: Hybridoma and Hybridomics, Vol. 21, No. 5, 01.01.2002, p. 339-349.

Research output: Contribution to journalArticle

Davern, S. M. ; Lankford, P. K. ; Foote, L. J. ; Kennel, Stephen. / Monoclonal antibodies to CD44 epitopes on mouse endothelium. In: Hybridoma and Hybridomics. 2002 ; Vol. 21, No. 5. pp. 339-349.
@article{9a2519656666490181f49875682c9b13,
title = "Monoclonal antibodies to CD44 epitopes on mouse endothelium",
abstract = "CD44 is a widely expressed, plasma membrane protein. Many molecular forms of CD44 are possible as it is encoded by a gene with multiple exons that can be alternatively spliced and its deduced protein sequence contains numerous glycosylation sites. Through its role as an adhesion molecule, CD44 is involved in many and diverse biological processes, including angiogenesis, lymphogenesis, wound healing, inflammation, and cancer metastasis. We have developed a new panel of rat monoclonal antibodies (MAbs) to murine CD44 by immunization with mouse lung endothelial cells (LEII cells). The antibodies were characterized using immunoprecipitation, mass spectrometry, competition binding, and cross Western blot experiments with MAb 133-13A, which recognizes CD44 expressed on tumor cells. The new MAbs recognize three distinct epitope groups. MAbs 531-2A and 531-32A compete for binding with the MAb 133-13A that was described previously. MAb 531-30A identifies a CD44 epitope found on low molecular weight forms expressed in vivo, while MAb 531-22A appears to recognize an epitope specific for endothelial cells. This novel panel of anti-CD44 antibodies has potential for investigating the role of CD44 in disease pathogenesis models in the mouse. They may be particularly useful for examining the role of endothelial cells in these models.",
author = "Davern, {S. M.} and Lankford, {P. K.} and Foote, {L. J.} and Stephen Kennel",
year = "2002",
month = "1",
day = "1",
doi = "10.1089/153685902761022689",
language = "English (US)",
volume = "21",
pages = "339--349",
journal = "Monoclonal Antibodies in Immunodiagnosis and Immunotherapy",
issn = "2167-9436",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Monoclonal antibodies to CD44 epitopes on mouse endothelium

AU - Davern, S. M.

AU - Lankford, P. K.

AU - Foote, L. J.

AU - Kennel, Stephen

PY - 2002/1/1

Y1 - 2002/1/1

N2 - CD44 is a widely expressed, plasma membrane protein. Many molecular forms of CD44 are possible as it is encoded by a gene with multiple exons that can be alternatively spliced and its deduced protein sequence contains numerous glycosylation sites. Through its role as an adhesion molecule, CD44 is involved in many and diverse biological processes, including angiogenesis, lymphogenesis, wound healing, inflammation, and cancer metastasis. We have developed a new panel of rat monoclonal antibodies (MAbs) to murine CD44 by immunization with mouse lung endothelial cells (LEII cells). The antibodies were characterized using immunoprecipitation, mass spectrometry, competition binding, and cross Western blot experiments with MAb 133-13A, which recognizes CD44 expressed on tumor cells. The new MAbs recognize three distinct epitope groups. MAbs 531-2A and 531-32A compete for binding with the MAb 133-13A that was described previously. MAb 531-30A identifies a CD44 epitope found on low molecular weight forms expressed in vivo, while MAb 531-22A appears to recognize an epitope specific for endothelial cells. This novel panel of anti-CD44 antibodies has potential for investigating the role of CD44 in disease pathogenesis models in the mouse. They may be particularly useful for examining the role of endothelial cells in these models.

AB - CD44 is a widely expressed, plasma membrane protein. Many molecular forms of CD44 are possible as it is encoded by a gene with multiple exons that can be alternatively spliced and its deduced protein sequence contains numerous glycosylation sites. Through its role as an adhesion molecule, CD44 is involved in many and diverse biological processes, including angiogenesis, lymphogenesis, wound healing, inflammation, and cancer metastasis. We have developed a new panel of rat monoclonal antibodies (MAbs) to murine CD44 by immunization with mouse lung endothelial cells (LEII cells). The antibodies were characterized using immunoprecipitation, mass spectrometry, competition binding, and cross Western blot experiments with MAb 133-13A, which recognizes CD44 expressed on tumor cells. The new MAbs recognize three distinct epitope groups. MAbs 531-2A and 531-32A compete for binding with the MAb 133-13A that was described previously. MAb 531-30A identifies a CD44 epitope found on low molecular weight forms expressed in vivo, while MAb 531-22A appears to recognize an epitope specific for endothelial cells. This novel panel of anti-CD44 antibodies has potential for investigating the role of CD44 in disease pathogenesis models in the mouse. They may be particularly useful for examining the role of endothelial cells in these models.

UR - http://www.scopus.com/inward/record.url?scp=0036936756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036936756&partnerID=8YFLogxK

U2 - 10.1089/153685902761022689

DO - 10.1089/153685902761022689

M3 - Article

VL - 21

SP - 339

EP - 349

JO - Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

JF - Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

SN - 2167-9436

IS - 5

ER -